News and Document archive source
copyrighted material disclaimer at bottom of page

NewsMinecabal-elitecorporatepharmaceutical — Viewing Item


Return of vioxx unusual not unprecendented

Original Source Link: (May no longer be active)
   http://www.usatoday.com/news/health/2005-02-21-vioxx-usat_x.htm

http://www.usatoday.com/news/health/2005-02-21-vioxx-usat_x.htm

Return of Vioxx would be unusual, not unprecedented
By Julie Schmit, USA TODAY

If Merck puts painkiller Vioxx back on the market after removing it because of safety concerns, it would be an unusual but not unprecedented event.
Among drugs approved by the Food and Drug Administration since 1990, 14 have been withdrawn from the U.S. market for safety reasons, says consumer watchdog group Public Citizen. Only Lotronex, approved to treat irritable bowel syndrome in women, has so far been reintroduced.

That happened in 2002, two years after Lotronex went off the market and only after the FDA restricted its use. Merck might likewise face restrictions on Vioxx, and that might make a re-launch unattractive, says Winton Gibbons, health care industry analyst with investment bank William Blair.

"It may not be economically advantageous," he says.

Merck pulled Vioxx from the market Sept. 30 after a study showed it increased cardiovascular risks for some users.

Last week, an FDA advisory panel decided that painkillers Vioxx, Celebrex and Bextra carry cardiovascular risks but recommended that the FDA support their being marketed. Merck suggested it would consider putting Vioxx back on the market if the FDA approved and if competing drugs stayed on the market.

What happened to Lotronex might dampen enthusiasm. The drug was pulled from the market in 2000, less than a year after it got FDA approval, by maker Glaxo Wellcome because of reports of severe gastrointestinal side affects. Glaxo and the FDA also couldn't agree on how to manage the risk.

The drug's removal caused an outcry from consumers. They lobbied the FDA, saying they would accept the drug's risk to get the benefit. An FDA advisory panel recommended it be returned to market with restrictions, which the FDA did in 2002. It restricted the drug to women with severe symptoms and for whom other treatments failed. Among other things, patients have to sign consent forms indicating they're aware of potential risks. Doctors must enroll in a program to assure they understand them.

GlaxoSmithKline, formed from a merger, doesn't break out Lotronex revenue because it's not one of the company's biggest-selling drugs. But its universe of users has shrunk.

From March 2000 to the following December, 534,000 Lotronex prescriptions were written for 275,000 patients, Glaxo says. From November 2002, after its return, to February 2004, only 35,000 prescriptions had been written for 10,000 patients.

Last week's FDA panel indicated a preference for all three painkillers to carry labels detailing their heart risk and for a ban on consumer advertising. The FDA's response is expected within weeks. It typically follows its panels' recommendations.

Several panel members also said Vioxx should only be available for pediatric use since it's the only one of the three so approved by the FDA. A handful of members suggested patient consent forms be required, and several recommended limiting Vioxx to patients for whom other drugs don't work.

"When you put all of those together ... it could be a small market," says Gibbons, who personally owns shares of Pfizer, maker of Celebrex and Bextra. Vioxx revenue hit $2.5 billion in 2003, and was one of Merck's biggest drugs.

Marketing experts, too, say it'll be tough for any of the drugs to woo back consumers who have found other options that work and carry less risk. For those who haven't, not even a strong warning label is likely to deter them unless they're in a high-risk group, says Pam Scholder Ellen, associate professor of marketing at Georgia State University. They might say, "Yes there is a danger but it's not going to happen to me," she says.

The panel's vote on Vioxx was 17-15; Bextra 17-13; Celebrex 31 to 1. The Vioxx vote, though largely split, might help Merck's defense against hundreds of lawsuits alleging that it knew long before it pulled Vioxx of its risks an allegation it denies. Andy Birchfield, one of the lead plaintiffs' attorneys, on Monday called on Merck to keep Vioxx off the market.



40 percent of americans take prescription drugs
ADD drugs give hallucinations of bugs and snakes { March 22 2006 }
American painkiller use skyrocketing
Anti depresents linked to suicide
Antibiotic causes liver damage
Antidepressant use by adults surges { December 3 2004 }
Antidepressants addictive to some people { August 6 2006 }
Antidepressants remove obsessive focus of love
Antidepressiants increases chance of suicide { December 13 2006 }
Arthritis drugs causing cancer in childen { April 29 2008 }
Bayer sent riskier drug asia latinamerica { May 22 2003 }
Birth defects from paxil in pregnant women { December 8 2005 }
Canada makes drug deals with 2 states against fda wishes { October 5 2004 }
Cholesterol drug causes kidney damage contradicting fda { May 24 2005 }
Cholesterol meds lower test results not improving health { January 15 2008 }
Clinical trials biased by profit funding
Company hid heartattack data for painkiller { December 8 2005 }
Congressman moves retired to drug lobby
Dc council legislation blocks pharmaceutical price gounging { September 21 2005 }
Doctor gives anti depressants to 4 yr old girl
Doctors get kickbacks to promote drugs
Doctors prescribe paxil whenever asked { April 27 2005 }
Drug aleve increases stroke heart attack risk { December 21 2004 }
Drug bill well financed victory
Drug company criminal charges { May 31 2003 }
Drug firms hide studies showing suicidal behavior { September 10 2004 }
Drug firms hype up diseases to boost sales
Drug leader at NIH takes pharmaceutical money { December 22 2004 }
Fda accused too cozy with pharmaceuticals { November 18 2004 }
Fda approval surprises many doctors
Fda prevented drug expert from speaking on anti depressants { April 16 2004 }
Fda wants suicide warning on anti depressants { March 23 2004 }
Fda whistle blower seeks legal help { November 24 2004 }
Fraud studies made by drug company { March 2008 }
Man arrested if not medicating child with drugs { June 7 2004 }
Mccain knocks steroids baseball
Minnesota school shooter using prozac and others { March 26 2005 }
More anti depressant drug warnings by fda
New diabetes pill poses deadly risk
New york state sues paxil company over coverup { June 3 2004 }
Newer antipsychotic drugs more costly less effective { September 20 2005 }
Parents reverse child hyper activity without drugs { December 22 2006 }
Paxil link found with birth defects
Pharmaceutical cholesterol drugs not lowering risk
Pharmaceutical companies court doctors for sells { April 11 2008 }
Pharmaceutical companies using tax exempt charities { June 28 2006 }
Pharmaceutical secrecy on antidepressant data { January 29 2004 }
Pharmaceuticals in tap water through sewage { March 10 2008 }
Pharmaceuticals pay fda more for speedy approvals { November 22 2006 }
Return of vioxx unusual not unprecendented
Rise of european behavior controlling drug
Ritalin could be dangerous to heart { February 10 2006 }
Senators told fda too cozy with drug industry { November 18 2004 }
Sharp rise in ritalin { July 19 2003 }
Sleeping pill causes sleep driving { March 15 2007 }
Sleeping pills once a day increase death rate { March 23 2006 }
Statin drug takers suffer heart attacks anyway
Study criticizes painkiller marketing { January 25 2005 }
Study drugs for students growing { June 11 2006 }
Study shows no good effect from anti depressants { February 25 2008 }
Suicide risk increase with antidepressants { February 18 2005 }
Supreme court allows pharmaceutical to bulldoze homes { June 23 2005 }
Teens increasing pharmaceutical drug abuse { April 21 2005 }
Teens use pharmaceutical drugs to get high { December 21 2006 }
Unapproved drug tested on children in nigeria { May 7 2006 }
Unfavorable drug studies never reported
Viox risk seen with short term use { May 17 2006 }
Women participating in lilly drug trial hangs self { February 9 2004 }

Files Listed: 68



Correction/submissions

CIA FOIA Archive

National Security
Archives
Support one-state solution for Israel and Palestine Tea Party bumper stickers JFK for Dummies, The Assassination made simple